Evotec AG announced recently that it will receive funding of up to €1.5 million from the German Federal Ministry of Education and Research to advance its H3 receptor antagonist programme into the clinic.
29 April, 2010
Hearing loss charity, RNID, is travelling to Chicago to launch a special issue of Drug Discovery Today at BIO International, the world’s largest biotechnology conference. RNID will be exhibiting at booth number 4707 Produced in association with RNID and Fight for Sight, the publication highlights the exciting progress being made in developing treatments for hearing and vision loss.
23 April, 2010
Scientists have made a major breakthrough in identifying new treatments for human African trypanosomiasis, a fatal disease that infects tens of thousands of Africans each year.
01 April, 2010